Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion

Pharmacology, Toxicology and Pharmaceutical Science

• Combination Therapy 100%
• Ischemia 100%
• Esmolol 100%
• Milrinone 100%
• Infarction 20%
• Protein Kinase B 20%
• Antiapoptotic 10%
• Phosphotransferase Inhibitor 10%
• Rat Model 5%
• Heart Infarction 5%
• Adverse Event 5%
• Mortality Rate 5%
• Table Salt 5%
• Cyclic AMP Dependent Protein Kinase 5%
• Hypoxia 5%
• Adrenergic Receptor Blocking Agent 5%
• Phosphodiesterase III Inhibitor 5%

Keyphrases

• Early Reperfusion Therapy 10%
• PKA Activity 5%
• Cardiomyocyte Culture 5%
• Phosphodiesterase 3 Inhibitor 5%